This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Dovato
  • /
  • Switch Study to Evaluate Dolutegravir Plus Lamivud...
Clinical trial

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

Read time: 2 mins
Last updated:1st Jun 2020
Status: Active, not recruiting
Identifier: NCT03446573
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest